Human Medicines
This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Decisions on additional year of market protection/data exclusivity for new…
modified 04/10/2024
Added in October 2024
4 October
UPDATE - Decisions on additional year of…
modified 04/10/2024
Referral decisions and new product information changes can be found on:
the…
modified 02/10/2024
Contact Points
modified 01/10/2024
Template of letter of intent for the submission of a worksharing procedure (June…
modified 30/09/2024
Added in September 2024
25 September
NEW - Report from the meeting held on…
modified 25/09/2024
Overview of timetables
modified 25/09/2024
Vaxigrip Tetra (quadrivalent influenza virus vaccine (inactivated,…
modified 25/09/2024
Loperamide, loperamide/simethiconeEnd of procedure: 25/05/2024Date of…
added 25/09/2024
List of active substances for which data has been submitted in accordance with…
modified 25/09/2024